Canada markets closed

ORPHAZYME A/S DK 150 (1TB0.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
139.000.00 (0.00%)
At close: 09:43PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
Total Revenue
36,193
36,193
0
Operating Expenses
Research Development
229,942
229,942
261,136
Selling General and Administrative
391,395
421,443
342,199
Total Operating Expenses
639,448
669,496
608,534
Operating Income or Loss
-603,255
-633,303
-608,534
Interest Expense
9,458
9,458
14,114
Total Other Income/Expenses Net
-
11,391
-12,406
Income Before Tax
-601,400
-631,480
-635,161
Income Tax Expense
-5,416
-4,941
-1,915
Income from Continuing Operations
-595,984
-626,539
-633,246
Net Income
-99,776
-626,539
-633,246
Net Income available to common shareholders
-99,776
-626,539
-633,246
Basic EPS
-2.88k
-17.94k
-22.32k
Diluted EPS
-2.88k
-17.94k
-22.32k
Basic Average Shares
35.098
34.924
28.366
Diluted Average Shares
35.312
34.924
28.366